DVA
DAVITA INC.
NYSE · Healthcare · Medical - Care Facilities · US
$193.31
+5.10%Year over year
Reported trailing growth
- Revenue
- +6.4%
- EBITDA
- +2.0%
- EBIT
- +1.6%
- EPS
- +11.7%
- Free cash flow
- +24.9%
- Operating cash flow
- +17.7%
Forward estimates
Based on analyst estimates
- Revenue
- +2.5%
- EBITDA
- -6.8%
- EPS
- +39.3%
Three-year CAGR
- Revenue
- +5.5%
- EBITDA
- +8.7%
- EBIT
- +14.5%
- Net income
- +10.0%
- EPS
- +18.2%
- Free cash flow
- +10.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026